Tatsuta M, Iishi H, Nakaizumi A, Okuda S
Department of Gastrointestinal Oncology, Center for Adult Diseases, Osaka, Japan.
Aliment Pharmacol Ther. 1992 Apr;6(2):221-8. doi: 10.1111/j.1365-2036.1992.tb00265.x.
The effects on gastric emptying and gastrointestinal symptoms of treatment with cisapride alone and in combination with domperidone were investigated in 25 patients with chronic idiopathic dyspepsia. In a double-blind study, 9 patients were randomly assigned to receive cisapride 2.5 mg three times daily, and 8 patients to receive placebo. After 7 days of treatment, gastric emptying was significantly accelerated and the score of gastrointestinal symptoms was significantly reduced in patients treated with cisapride. Placebo treatment had no significant effect. A randomized, double-blind crossover study of 8 patients compared the effects of combined treatment with cisapride 2.5 mg plus domperidone 10 mg three times daily for 7 days against the effects of cisapride plus placebo. Administration of cisapride plus domperidone gave significantly higher gastric emptying and lower gastrointestinal symptoms than cisapride plus placebo.
在25例慢性特发性消化不良患者中,研究了西沙必利单独治疗以及与多潘立酮联合治疗对胃排空和胃肠道症状的影响。在一项双盲研究中,9例患者被随机分配接受西沙必利2.5毫克,每日三次,8例患者接受安慰剂。治疗7天后,接受西沙必利治疗的患者胃排空明显加快,胃肠道症状评分显著降低。安慰剂治疗无显著效果。一项对8例患者进行的随机双盲交叉研究比较了西沙必利2.5毫克加多潘立酮10毫克每日三次联合治疗7天与西沙必利加安慰剂的效果。西沙必利加多潘立酮的给药方式比西沙必利加安慰剂产生了显著更高的胃排空率和更低的胃肠道症状。